RNR · Insider Trading

RenaissanceRe Holdings Ltd.

Every open-market purchase and sale reported by RNR officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.

Form 4 Filings
50
most recent
Open-Market Buys
0
code P
Sales
11
code S
Reporting Insiders
19
current holders
RNR — Recent Form 4 Transactions (latest 2026-09-03)
FiledInsiderRole TypeSharesValue
2026-09-03 Ross Curtis EVP,Chief Portfolio Officer Sell −9,623 −$3.25M
2026-08-27 Ross Curtis EVP,Chief Portfolio Officer Sell −377 −$126.30K
2026-08-25 Ross Curtis EVP,Chief Portfolio Officer Sell −5,000 −$1.65M
2026-08-17 Ross Curtis EVP,Chief Portfolio Officer Sell −5,000 −$1.62M
2026-07-28 Robert Qutub EVP, Chief Financial Officer Sell −5,000 −$1.67M
2026-05-19 Carol P Sanders Director Sell −1,479 −$439.79K
2026-05-12 Stephen C Hooley Director A +591 —
2026-05-12 Henry Klehm III Director A +506 —
2026-05-06 David C Bushnell Director — — —
2026-03-12 Robert Qutub EVP, Chief Financial Officer MIXED −4,066 −$917.52K
2026-03-12 Ross Curtis EVP,Chief Portfolio Officer D −1,070 —
2026-03-12 Kevin ODonnell Pres & Chief Executive Officer MIXED −10,071 −$2.27M
2026-03-12 David E Marra EVP,Chief Underwriting Officer MIXED −3,282 −$781.69K
2026-03-12 Shannon Lowry Bender EVP, General Counsel & Secty MIXED −2,008 −$453.26K
2026-03-03 James Christopher Fraser SVP, Chief Accounting Officer A +1,611 —
2026-03-03 David E Marra EVP,Chief Underwriting Officer MIXED +10,948 −$288.24K
2026-03-03 Kevin ODonnell Pres & Chief Executive Officer MIXED +29,705 −$1.42M
2026-03-03 Ross Curtis EVP,Chief Portfolio Officer A +10,248 —
2026-03-03 Sean G Brosnan SVP, Chief Investment Officer A +6,343 —
2026-03-03 Shannon Lowry Bender EVP, General Counsel & Secty MIXED +6,243 −$271.61K
2026-03-03 Robert Qutub EVP, Chief Financial Officer MIXED +8,950 −$492.40K
2026-03-03 Shyam H Gidumal Director A +578 —
2026-03-03 Henry Klehm III Director A +578 —
2026-03-03 Torsten Jeworrek Director A +578 —
2026-03-03 Carol P Sanders Director A +578 —
2026-03-03 Cynthia Trudell Director A +578 —
2026-03-03 Duncan P Hennes Director A +578 —
2026-03-03 David C Bushnell Director A +578 —
2026-03-03 Valerie Rahmani Director A +578 —
2026-03-03 Loretta J. Mester Director A +578 —
2026-03-03 James L Gibbons Director A +1,074 —
2026-02-17 David E Marra EVP,Chief Underwriting Officer F −1,271 −$383.04K
2026-02-06 Ross Curtis EVP,Chief Portfolio Officer Sell −20,000 −$5.95M
2026-02-06 Robert Qutub EVP, Chief Financial Officer Sell −5,000 −$1.53M
2025-11-04 David E Marra EVP,Chief Underwriting Officer F −653 −$165.92K
2025-08-13 David C Bushnell Director Sell −5,844 −$1.41M
2025-07-17 David E Marra EVP,Chief Underwriting Officer Sell −1,000 −$237.38K
2025-05-08 James Christopher Fraser SVP, Chief Accounting Officer Sell −14,000 −$3.51M
2025-03-12 Robert Qutub EVP, Chief Financial Officer MIXED −4,836 −$890.37K
2025-03-12 Ross Curtis EVP,Chief Portfolio Officer D −1,246 —
2025-03-12 Kevin ODonnell Pres & Chief Executive Officer MIXED −14,925 −$2.75M
2025-03-04 Loretta J. Mester Director A +694 —
2025-03-04 Carol P Sanders Director A +694 —
2025-03-04 David E Marra EVP,Chief Underwriting Officer MIXED +13,371 −$197.46K
2025-03-04 Valerie Rahmani Director A +694 —
2025-03-04 Sean G Brosnan SVP, Chief Investment Officer A +3,866 —
2025-03-04 James Christopher Fraser SVP, Chief Accounting Officer A +2,472 —
2025-03-04 Henry Klehm III Director A +694 —
2025-03-04 Shyam H Gidumal Director A +694 —
2025-03-04 Duncan P Hennes Director A +694 —
RNR — Current Insider Holders
InsiderRole Shares HeldValue
Kevin ODonnell Pres & Chief Executive Officer 445,549 $156.62M
Ross Curtis EVP,Chief Portfolio Officer 160,991 $56.59M
David E Marra EVP,Chief Underwriting Officer 95,465 $33.56M
Robert Qutub EVP, Chief Financial Officer 72,907 $25.63M
Sean G Brosnan SVP, Chief Investment Officer 40,565 $14.26M
Shannon Lowry Bender EVP, General Counsel & Secty 36,122 $12.70M
James L Gibbons Director 32,462 $11.41M
Brian Gerald John Gray Director 25,118 $8.83M
Henry Klehm III Director 20,824 $7.32M
James Christopher Fraser SVP, Chief Accounting Officer 15,097 $5.31M
David C Bushnell Director 13,439 $4.72M
Valerie Rahmani Director 8,696 $3.06M
Duncan P Hennes Director 8,696 $3.06M
Cynthia Trudell Director 6,534 $2.30M
Carol P Sanders Director 5,762 $2.03M
Shyam H Gidumal Director 3,809 $1.34M
Torsten Jeworrek Director 2,793 $981.82K
Loretta J. Mester Director 1,865 $655.60K
Stephen C Hooley Director 591 $207.75K
RNR Insider Trading FAQ
Who are the insiders at RNR?
19 officers, directors and 10%+ beneficial owners currently report holdings in RNR via SEC Form 4.
Are RNR insiders buying or selling?
Across the 50 most recent Form 4 filings for RNR, 0 were open-market purchases (code P) and 11 were sales (code S). Sales frequently reflect scheduled 10b5-1 plans or tax withholding rather than a view on the stock.
How current is RNR insider data?
Form 4 must be filed within two business days of the transaction, so this is close to real time. The most recent RNR filing is dated 2026-09-03.
How to read Form 4 activity

Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.

Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.

Full filing history and per-insider positions are on the RNR quote page; the site-wide leaderboard is on the insider transactions hub.

Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.